A recent study found that people who received Zostavax, a older shingles vaccine, had a lower risk of developing dementia.

The findings could have implications for managing the growing burden of dementia.

CINCINNATI (WKRC)— A new study suggests that the shingles vaccine could play a role in reducing the risk of memory problems, offering hope to those working to prevent dementia and Alzheimer's disease.

New research shows the shingles vaccine could protect against dementia — Dr. Archelle Georgiou explains the science behind the news.

A Welsh health policy provided a rare opportunity for researchers to examine the real-life impact of a vaccine and dementia ...

Well, the surprising discovery is here! Research now demonstrates that the herpes zoster (shingles) vaccine produces a significant reduction in dementia rates. The study named "A Natural Experiment on ...

Weeks after ordering Food and Drug Administration employees back into the office, the agency is reversing course, allowing some of its most prized staffers to work remotely amid worries that recent ...